Crizotinib, Lung Cancer Drug, Shows Big Promise In Early Tests - huffingtonpost

CHICAGO — It's way too soon to declare success, but an experimental drug for lung cancer patients with a certain gene showed extraordinary promise in early testing, doctors reported at a cancer conference on Saturday. Crizotinib, Lung Cancer Drug, Shows Big Promise In Early Tests

New Lung Cancer Drug Shows Big Promise In Early Tests

Folic Acid: Killer Or Cure-All? - Mark Hyman, MD